TrialThe oncologist2020

Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial.

Zhenhuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.